Laboratory-acquired meningococcal disease--United States, 2000.
暂无分享,去创建一个
[1] L S Geiss,et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. , 2001, Diabetes care.
[2] C. Kibbler. Laboratory-acquired Infections: History, Incidence, Causes and Preventions, 4th ed. , 2000 .
[3] K. Fiscella,et al. Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. , 2000, JAMA.
[4] N. Adler,et al. Socioeconomic Status and Health: What We Know and What We Don't , 1999, Annals of the New York Academy of Sciences.
[5] M. Engelgau,et al. Population-Based Assessment of the Level of Care Among Adults With Diabetes in the U.S , 1998, Diabetes Care.
[6] David R. Williams,et al. Measuring social class in US public health research: concepts, methodologies, and guidelines. , 1997, Annual review of public health.
[7] Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[8] C. Cowie,et al. Sociodemographic Characteristics of Persons with Diabetes , 1996 .
[9] R. Klein,et al. The relation of socioeconomic factors to the incidence of proliferative diabetic retinopathy and loss of vision. , 1994, Ophthalmology.